Newsom S W, Murphy P, Matthews J
J Antimicrob Chemother. 1986 Nov;18 Suppl D:111-5. doi: 10.1093/jac/18.supplement_d.111.
A prospective, comparative clinical trial of ciprofloxacin (100 mg bd) versus trimethoprim (200 mg bd), both for five days, was carried out in 40 geriatric patients with urinary tract infection. Thirty-two could be assessed for drug efficacy, and all forty for toxicity studies. Both drugs were equally safe, and ciprofloxacin was at least as effective as trimethoprim as far as clinical response was concerned. Ciprofloxacin appeared more effective in eradication of bacteria. Antibacterial activity was found in urine and faeces up to five days after stopping ciprofloxacin therapy.
对40例老年尿路感染患者进行了一项前瞻性、比较性临床试验,比较环丙沙星(每日2次,每次100毫克)与甲氧苄啶(每日2次,每次200毫克),疗程均为5天。32例可评估药物疗效,40例均进行毒性研究。两种药物安全性相当,就临床反应而言,环丙沙星至少与甲氧苄啶一样有效。环丙沙星在根除细菌方面似乎更有效。在停止环丙沙星治疗后长达5天的尿液和粪便中均发现抗菌活性。